Explore the complete record of transactions filed by Riley Antony A, Chief Financial Officer. Insider active across 1 companies, notably Forte Biosciences, Inc.. Aggregated, 2 filings have been recorded. Total volume traded: €154k. The latest transaction was disclosed on 7 September 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Riley Antony A is the Chief Financial Officer at Forte Biosciences, Inc. In this role, he oversees the company's financial operations, including accounting, financial planning, and risk management. Antony is responsible for developing financial strategies that support the company's growth objectives. His expertise in finance is essential for ensuring the financial health of Forte Biosciences.